PharmaBoardroom

Our contributor at large, David Crean, Managing Director for Objective Capital Partners, attended J.P. Morgan's 2019 Health Care Investor…

The Top 10 bestselling patented medicines in Canada for 2017. Janssen sold CND 938.1 million of its Remicade treatment for gastroenterology,…

Examining what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. Here, Eugene Kim,…

Damaso Molero, general manager of 3P Biopharmaceuticals, a leading Spanish CDMO, highlights the growth of the company and the need to continuously…

Daniel-Anibal Garcia Diego, president of the Spanish Haemophilia Federation (FEDHEMO), discusses the current situation of haemophilia treatment and…

Eduardo Barriga, general manager of Boiron, the homeopathic market leader in Spain, discusses the company’s approach to the Spanish market since he…

Nawal Roy is founder and CEO of Holmusk, a company dedicated to building one of the world’s largest real-world evidence platforms for neurosciences.…

China is set to become the second largest market for Mundipharma’s OxyContin behind the US. It comes as no surprise that sales of…

Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on…

As the 3rd largest pharma region in Asia, Korea's booming pharma industry owes much to its mass of family-run conglomerates known as Chaebol. It…

Carla Smith is a healthcare thought leader with nearly 30 years' experience. She champions transformational strategy, governance, and policy in the…

After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research…